(Q24800075)

English

Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years

scientific article

In more languages

Statements

scholarly article

0 references

Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years (English)

0 references

Alzheimer's disease

1 reference

based on heuristic

author name string

Martin R Farlow

1

0 references

Mary L Lilly

2

0 references

language of work or name

0 references

publication date

2005

0 references

0 references

5

0 references

1

0 references

3

0 references

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

28 September 2017

Dementia diagnostic guidelines: methodologies, results, and implementation costs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

28 September 2017

Diagnosis, management, and treatment of Alzheimer disease: a guide for the internist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

28 September 2017

Factors affecting the age of onset and rate of progression of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

28 September 2017

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

28 September 2017

The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

Age at onset and rate of progression of Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

Predictors of decline in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

30 May 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-5-3

21 January 2018

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-5-3

21 January 2018

Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-5-3

21 January 2018

Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XII.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-5-3

21 January 2018

Rate of progression and prognostic factors in Alzheimer's disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-5-3

21 January 2018

Predicting time to nursing home care and death in individuals with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-5-3

21 January 2018

Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-5-3

21 January 2018

Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

28 November 2018

Age of onset and brain atrophy in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=548267

28 November 2018

A method for estimating progression rates in Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15659242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2318-5-3

0 references

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2318-5-3

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24800075&oldid=2176925862"